Factors and barriers to sulfadoxine-pyrimethamine uptake for intermittent preventive treatment during pregnancy in Ghana
Malaria continues to pose a significant threat to pregnant women in sub-Saharan Africa, including Ghana, where the uptake of intermittent preventive treatment in pregnancy with sulfadoxine-pyrimethamine (IPTp-SP) remains below optimal levels. This study explored factors influencing IPTp-S...
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Academia.edu Journals
2024-11-01
|
| Series: | Academia Medicine |
| Online Access: | https://www.academia.edu/125709976/Factors_and_barriers_to_sulfadoxine_pyrimethamine_uptake_for_intermittent_preventive_treatment_during_pregnancy_in_Ghana |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1823859710425563136 |
|---|---|
| author | Akua Kumi Yeboah Patrick Ohemeng Gyaase Richmond Bediako Nsiah Regina Amoa-Tutu Saida Abdul-Rahman Zakaria Lynna Naa Adede Obeng Frank Prempeh Phenihas Kwadwo Opoku Amos Andoono Gilbert Elara Dagoe Kwame Kusi Agyemang Jonathan Mawutor Gmanyami Dominic Nyarko Paul Kofi Awuah Gifty Sefaah Owusu Solomon Anum-Doku |
| author_facet | Akua Kumi Yeboah Patrick Ohemeng Gyaase Richmond Bediako Nsiah Regina Amoa-Tutu Saida Abdul-Rahman Zakaria Lynna Naa Adede Obeng Frank Prempeh Phenihas Kwadwo Opoku Amos Andoono Gilbert Elara Dagoe Kwame Kusi Agyemang Jonathan Mawutor Gmanyami Dominic Nyarko Paul Kofi Awuah Gifty Sefaah Owusu Solomon Anum-Doku |
| author_sort | Akua Kumi Yeboah |
| collection | DOAJ |
| description |
Malaria continues to pose a significant threat to pregnant women in sub-Saharan Africa, including Ghana, where the uptake of intermittent preventive treatment in pregnancy with sulfadoxine-pyrimethamine (IPTp-SP) remains below optimal levels. This study explored factors influencing IPTp-SP uptake among 300 postpartum mothers in Asunafo North Municipal using a descriptive cross-sectional design. Data were gathered through pretested questionnaires, and statistical analyses included descriptive, bivariate, and multivariate methods, with logistic regression used to assess relationships at a significance level of α = 0.05. A significant proportion (43.7%) of participants received three or more doses of IPTp-SP, while 56.3% received two or fewer doses. Key barriers to uptake included being unmarried (AOR = 0.36, [95% CI 0.145–0.881], p = 0.025) and unemployed (COR = 0.61, [95% CI 0.38–0.98], p = 0.042). Fewer antenatal care (ANC) visits (≤3 times) were strongly associated with lower odds of receiving three or more doses (AOR = 0.03, [95% CI 0.01–0.83], p < 0.001). Higher IPTp-SP uptake was positively linked to the perceived severity of malaria in pregnancy (AOR = 0.19, [95% CI 1.02–4.20], p = 0.045) and the perceived benefits of IPTp-SP (AOR = 0.39, [95% CI 0.19–0.78], p = 0.008). Perceived susceptibility to malaria did not significantly affect uptake. Sociodemographic factors such as age, education, and parity showed no significant associations. Major barriers included time and financial constraints related to ANC attendance. The study underscores the need for better alignment between ANC attendance and IPTp-SP administration, and suggests that future research should evaluate ANC interventions to enhance IPTp-SP uptake and reduce malaria-related complications. |
| format | Article |
| id | doaj-art-b1e6c25052ce4cbeae073fcd3685fa9b |
| institution | Kabale University |
| issn | 2994-435X |
| language | English |
| publishDate | 2024-11-01 |
| publisher | Academia.edu Journals |
| record_format | Article |
| series | Academia Medicine |
| spelling | doaj-art-b1e6c25052ce4cbeae073fcd3685fa9b2025-02-10T22:25:45ZengAcademia.edu JournalsAcademia Medicine2994-435X2024-11-011410.20935/AcadMed7414Factors and barriers to sulfadoxine-pyrimethamine uptake for intermittent preventive treatment during pregnancy in GhanaAkua Kumi Yeboah0Patrick Ohemeng Gyaase1Richmond Bediako Nsiah2Regina Amoa-Tutu3Saida Abdul-Rahman Zakaria4Lynna Naa Adede Obeng5Frank Prempeh6Phenihas Kwadwo Opoku7Amos Andoono8Gilbert Elara Dagoe9Kwame Kusi Agyemang10Jonathan Mawutor Gmanyami11Dominic Nyarko12Paul Kofi Awuah13Gifty Sefaah Owusu14Solomon Anum-Doku15Public Health Department, Ghana Health Service, Ahafo Region, Goaso HR0001, Ghana.School of Public Health, Catholic University of Ghana, Sunyani BY0547, Ghana.Public Health Department, Ghana Health Service, Ashanti Region, Kumasi AK037, Ghana.Clinical Department, Ghana Health Service, Ashanti Region, Kumasi AK037, Ghana.Public Health Department, Ghana Health Service, Ashanti Region, Kumasi AK037, Ghana.Clinical Department, Ghana Health Service, Ashanti Region, Kumasi AK037, Ghana.Clinical Department, Ghana Health Service, Ashanti Region, Kumasi AK037, Ghana.Clinical Department, Ghana Health Service, Ashanti Region, Kumasi AK037, Ghana.Public Health Department, Ghana Health Service, Ashanti Region, Kumasi AK037, Ghana.Public Health Department, Ghana Health Service, Ashanti Region, Kumasi AK037, Ghana.Clinical Department, Ghana Health Service, Ashanti Region, Kumasi AK037, Ghana.Global Health and Infectious Diseases Research Group, Kumasi Centre for Collaborative Research in Tropical Medicine, Ashanti Region, Kumasi AK313, Ghana.Public Health Department, Ghana Health Service, Ashanti Region, Kumasi AK037, Ghana.Clinical Health Department, Ghana Health Service, Central Region, Cape Coast CC079, Ghana.Public Health Department, Ghana Health Service, Ashanti Region, Kumasi AK037, Ghana.Public Health Department, Ghana Health Service, Ashanti Region, Kumasi AK037, Ghana. Malaria continues to pose a significant threat to pregnant women in sub-Saharan Africa, including Ghana, where the uptake of intermittent preventive treatment in pregnancy with sulfadoxine-pyrimethamine (IPTp-SP) remains below optimal levels. This study explored factors influencing IPTp-SP uptake among 300 postpartum mothers in Asunafo North Municipal using a descriptive cross-sectional design. Data were gathered through pretested questionnaires, and statistical analyses included descriptive, bivariate, and multivariate methods, with logistic regression used to assess relationships at a significance level of α = 0.05. A significant proportion (43.7%) of participants received three or more doses of IPTp-SP, while 56.3% received two or fewer doses. Key barriers to uptake included being unmarried (AOR = 0.36, [95% CI 0.145–0.881], p = 0.025) and unemployed (COR = 0.61, [95% CI 0.38–0.98], p = 0.042). Fewer antenatal care (ANC) visits (≤3 times) were strongly associated with lower odds of receiving three or more doses (AOR = 0.03, [95% CI 0.01–0.83], p < 0.001). Higher IPTp-SP uptake was positively linked to the perceived severity of malaria in pregnancy (AOR = 0.19, [95% CI 1.02–4.20], p = 0.045) and the perceived benefits of IPTp-SP (AOR = 0.39, [95% CI 0.19–0.78], p = 0.008). Perceived susceptibility to malaria did not significantly affect uptake. Sociodemographic factors such as age, education, and parity showed no significant associations. Major barriers included time and financial constraints related to ANC attendance. The study underscores the need for better alignment between ANC attendance and IPTp-SP administration, and suggests that future research should evaluate ANC interventions to enhance IPTp-SP uptake and reduce malaria-related complications.https://www.academia.edu/125709976/Factors_and_barriers_to_sulfadoxine_pyrimethamine_uptake_for_intermittent_preventive_treatment_during_pregnancy_in_Ghana |
| spellingShingle | Akua Kumi Yeboah Patrick Ohemeng Gyaase Richmond Bediako Nsiah Regina Amoa-Tutu Saida Abdul-Rahman Zakaria Lynna Naa Adede Obeng Frank Prempeh Phenihas Kwadwo Opoku Amos Andoono Gilbert Elara Dagoe Kwame Kusi Agyemang Jonathan Mawutor Gmanyami Dominic Nyarko Paul Kofi Awuah Gifty Sefaah Owusu Solomon Anum-Doku Factors and barriers to sulfadoxine-pyrimethamine uptake for intermittent preventive treatment during pregnancy in Ghana Academia Medicine |
| title | Factors and barriers to sulfadoxine-pyrimethamine uptake for intermittent preventive treatment during pregnancy in Ghana |
| title_full | Factors and barriers to sulfadoxine-pyrimethamine uptake for intermittent preventive treatment during pregnancy in Ghana |
| title_fullStr | Factors and barriers to sulfadoxine-pyrimethamine uptake for intermittent preventive treatment during pregnancy in Ghana |
| title_full_unstemmed | Factors and barriers to sulfadoxine-pyrimethamine uptake for intermittent preventive treatment during pregnancy in Ghana |
| title_short | Factors and barriers to sulfadoxine-pyrimethamine uptake for intermittent preventive treatment during pregnancy in Ghana |
| title_sort | factors and barriers to sulfadoxine pyrimethamine uptake for intermittent preventive treatment during pregnancy in ghana |
| url | https://www.academia.edu/125709976/Factors_and_barriers_to_sulfadoxine_pyrimethamine_uptake_for_intermittent_preventive_treatment_during_pregnancy_in_Ghana |
| work_keys_str_mv | AT akuakumiyeboah factorsandbarrierstosulfadoxinepyrimethamineuptakeforintermittentpreventivetreatmentduringpregnancyinghana AT patrickohemenggyaase factorsandbarrierstosulfadoxinepyrimethamineuptakeforintermittentpreventivetreatmentduringpregnancyinghana AT richmondbediakonsiah factorsandbarrierstosulfadoxinepyrimethamineuptakeforintermittentpreventivetreatmentduringpregnancyinghana AT reginaamoatutu factorsandbarrierstosulfadoxinepyrimethamineuptakeforintermittentpreventivetreatmentduringpregnancyinghana AT saidaabdulrahmanzakaria factorsandbarrierstosulfadoxinepyrimethamineuptakeforintermittentpreventivetreatmentduringpregnancyinghana AT lynnanaaadedeobeng factorsandbarrierstosulfadoxinepyrimethamineuptakeforintermittentpreventivetreatmentduringpregnancyinghana AT frankprempeh factorsandbarrierstosulfadoxinepyrimethamineuptakeforintermittentpreventivetreatmentduringpregnancyinghana AT phenihaskwadwoopoku factorsandbarrierstosulfadoxinepyrimethamineuptakeforintermittentpreventivetreatmentduringpregnancyinghana AT amosandoono factorsandbarrierstosulfadoxinepyrimethamineuptakeforintermittentpreventivetreatmentduringpregnancyinghana AT gilbertelaradagoe factorsandbarrierstosulfadoxinepyrimethamineuptakeforintermittentpreventivetreatmentduringpregnancyinghana AT kwamekusiagyemang factorsandbarrierstosulfadoxinepyrimethamineuptakeforintermittentpreventivetreatmentduringpregnancyinghana AT jonathanmawutorgmanyami factorsandbarrierstosulfadoxinepyrimethamineuptakeforintermittentpreventivetreatmentduringpregnancyinghana AT dominicnyarko factorsandbarrierstosulfadoxinepyrimethamineuptakeforintermittentpreventivetreatmentduringpregnancyinghana AT paulkofiawuah factorsandbarrierstosulfadoxinepyrimethamineuptakeforintermittentpreventivetreatmentduringpregnancyinghana AT giftysefaahowusu factorsandbarrierstosulfadoxinepyrimethamineuptakeforintermittentpreventivetreatmentduringpregnancyinghana AT solomonanumdoku factorsandbarrierstosulfadoxinepyrimethamineuptakeforintermittentpreventivetreatmentduringpregnancyinghana |